NDC 70360-079

This exact product or package identity exists in FDA auxiliary data but is not present in the current primary NDC product table. The package identity is preserved; status rows are reported source observations, not medical conclusions.

Requested NDC: 70360-079
Product root: 70360-079
Identity scope: Product
Primary current NDC product row: Not present

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 6 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
compounder	package	70360-079	70360-079-59	COMPOUNDER	Outsourcing facility compounded drug report	2019-1	2026-10-24
compounder	package	70360-079	70360-079-50	COMPOUNDER	Outsourcing facility compounded drug report	2019-1	2026-10-24
compounder	package	70360-079	70360-079-61	COMPOUNDER	Outsourcing facility compounded drug report	2019-1	2026-10-24
compounder	package	70360-079	70360-079-57	COMPOUNDER	Outsourcing facility compounded drug report	2019-1	2026-10-24
compounder	package	70360-079	70360-079-51	COMPOUNDER	Outsourcing facility compounded drug report	2019-1	2026-10-24
compounder	package	70360-079	70360-079-55	COMPOUNDER	Outsourcing facility compounded drug report	2019-1	2026-10-24

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 6 matching rows.

View current auxiliary records. · View the auxiliary file history.

Package NDC table
Package NDC
70360-079-57
70360-079-55
70360-079-50
70360-079-59
70360-079-51
70360-079-61

Compounder NDC reports#

Browse the complete compounder directory for this NDC · Browse every current compounder row in the unified auxiliary catalog · browse compounder source captures and parsed snapshots.

Establishment, FEI, Product NDC table
Establishment	FEI	Product NDC	Package NDC	Product	Active ingredients	Reporting period	Normalization
Leiter's Compounding	079215020	70360-079	70360-079-50	Ropivacaine Hydrochloride	2 mg/1 mL	2019-1	valid
Leiter's Compounding	079215020	70360-079	70360-079-51	Ropivacaine Hydrochloride	2 mg/1 mL	2019-1	valid
Leiter's Compounding	079215020	70360-079	70360-079-55	Ropivacaine Hydrochloride	2 mg/1 mL	2019-1	valid
Leiter's Compounding	079215020	70360-079	70360-079-57	Ropivacaine Hydrochloride	2 mg/1 mL	2019-1	valid
Leiter's Compounding	079215020	70360-079	70360-079-59	Ropivacaine Hydrochloride	2 mg/1 mL	2019-1	valid
Leiter's Compounding	079215020	70360-079	70360-079-61	Ropivacaine Hydrochloride	2 mg/1 mL	2019-1	valid

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.